Lilly 30x30 is the company's goal to create new access to quality health care for 30 million people in resource-limited settings by the year 2030. To reach that goal, we have to find new solutions across our business and with our partners.
SHOWING 5 of 19 PARTNERSHIPS
See AllTransCelerate is a nonprofit organization with the mission to collaborate across the biopharmaceutical...
AbbVie, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer Inc, Sanofi, UCB
Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...
Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., IFPMA, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis Pharma AG, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB
Aiming to speed up the discovery and development of novel compounds against tuberculosis (TB)....
AbbVie, AstraZeneca, Bayer AG, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, MSD
The Global Alliance for TB Drug Development (TB Alliance) brings together industry, NGOs, governments,...
AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis Pharma AG
Creating wider awareness of what is being done to speed cancer innovations to the patients who need them. ...
Eli Lilly and Company
SHOWING 5 of 19 PARTNERSHIPS
See All